Ms. Iurkova is experienced in brand promotion, business development, marketing communications, and public relations. Prior to becoming Business Development Director for BIOMEDICA CRO, Iryna worked at Deloitte, Bayer, and AB InBev. She has a Master’s Degree in International Business Management. For the last seven years, Iryna has successfully worked in the field of human biospecimens, managing numerous complex projects.
How FFPE Tumor Biospecimens Advance Digital PD-L1 Validation Across Multiple Cancer Types 🔬
FFPE tumor biospecimens play a fundamental ro...
Atopic Dermatitis Samples from BIOMEDICA CRO Used in Published Novartis Research 🔬
Atopic dermatitis (AD) is one of the most com...
Human Urine Samples for Cancer Research: Advancing Early Detection Through Urinary Exosome microRNA Profiling 🔬
Early cancer detection remains one of the gre...
BIOMEDICA CRO Biospecimens Contributed to Research on a Novel Antibody-Drug Conjugate for Small Cell Lung Cancer 🔬
Small cell lung cancer (SCLC) remains one of ...
BIOMEDICA CRO Supports Breakthrough Epigenetic Research Published in Journal of Biological Chemistry
BIOMEDICA CRO, a global biospecimen provider ...
How Research Biosamples from BIOMEDICA CRO Contribute to Scientific Discoveries Worldwide 🌍
🧬 Research Biosamples for Pharmaceutical, Aca...
Purchase Biosamples and Clinical Data for Real Scientific Progress 🔬
Before You Purchase Biosamples, You Can Get t...
